ArticleJournal of nanobiotechnology2026
Cold exposure-induced loss of beneficial gut bacterial sEV is associated with the pathogenesis of bone loss through pyroptosis pathway.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Recent studies suggest that cold temperature (CT) exposure contributes to osteoporosis. While the gut microbiota (GM) is a key regulator of host physiology, CT conditions significantly alter its composition. In this study, we found that co-housing with room temperature (RT) mice, as well as colonization with RT-donor GM, conferred protection against CT-induced bone loss. Using 16 S rRNA gene sequencing, we demonstrated that the CT-triggered decline in intestinal Bifidobacterium pseudolongum (B. p) abundance was rescued by co-housing with RT mice. Furthermore, oral administration of B. p effectively alleviated CT-induced bone loss. Mechanistically, we identified that small extracellular vesicles derived from Bifidobacterium. pseudolongum (B. p-sEVs) were taken up by bone tissue, where they enhanced osteogenesis and suppressed pyroptosis in bone marrow stromal cells (BMSCs). Collectively, our findings suggest that the GM helps preserve bone mass via bacterial sEVs, and that the reduction of B. p and its derived sEVs drives CT-induced bone loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.